Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @admetsys
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @admetsys
-
Admetsys is proud to announce that we have submitted our conformity assessment for a Class IIB medical device on 1.20.2020. Thank you for all the support. We will continue to work towards changing the landscape of hospital care.
#ArtificialPancreas#T1D#T2Dpic.twitter.com/TSBa6BuTav
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't wait! Apply for the MedTech Innovator 2020 Competition today. Paul and his team do an amazing job introducing you to key players and investors in medtech.https://twitter.com/lifesciencevc/status/1222558873745145856 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
US based
#health startup@admetsys attended our Value Proposition session today#MBRIF#Accelerator#SpringCohort#ServiceDelivery#Innovation#StartUp#UAEPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
الشركة الامريكية الناشئة في مجال
#الصحة@admetsys شاركت اليوم في جلسة عروض القيمة#مسرع_صندوق_محمد_بن_راشد_للابتكار#صندوق_محمد_بن_راشد_للابتكار#ابتكارات_دبي#دبي#الاماراتpic.twitter.com/W98esiEHyl
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
US based
#health startup@Admetsys attending our Business Model session today#MBRIF#Accelerator#SpringCohort#ServiceDelivery#Innovation#StartUp#UAEpic.twitter.com/FUg7217f4U
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
@admetsys - Artificial pancreas for#diabetes management. Admetsys has developed a first-of-its-kind#artificial#pancreas. See this Instagram video by@dr.ruchidass https://www.instagram.com/p/By5inEYHlWs/?utm_source=ig_web_options_share_sheet … leverages adaptive learning#algorithms#digitalhealthpic.twitter.com/5GU1ePJwHV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
“Steno Diabetes Center North Denmark” & Admetsys presenting data on (1036-P) “Closed Loop Glucose Control System for In-Hospital Use...”. There is a great unmet need for better blood sugar control and better outcomes in hospitalized critically ill patients with diabetes.
#ADA2019pic.twitter.com/ojiMMtEKmi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
“Steno Diabetes Center North Denmark” presenting (1036-P) “Closed-Loop Glucose Control System for In-Hospital Use: Extended Control Trials” at
#ADA2019. Addressing unmet clinical needs in#diabetes using advanced technologies@AalborgUH http://www.SDCN.dk@Admetsys@Reg_Nordpic.twitter.com/bhnpoSOQbe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
جلسة تحديد خطة العمل مع شركات
#الصحة@nabtahealth الاماراتية و@Admetsys الامريكية هذا الأسبوع#مسرع_صندوق_محمد_بن_راشد_للابتكار#الإمارات#السعودية#مسرع_صندوق_محمد_بن_راشد_للابتكار#صندوق_محمد_بن_راشد_للابتكا#ابتكارات_دبي#دبي#مسرع_دبي#رائد#ابتكر_الامارات#ريادةpic.twitter.com/qez2n6qYFV
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
Congratulations to the first group of our Spring Cohort members! Check out their incredible solutions:
@admetsys@kinteractapp#MBRIF#SpringCohort#MBRIFAccelerator#Innovation#UAE#Dubai#AbuDhabiHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
تهانينا للمجموعة الأولى من المبتكرين الذين تم اختيارهم ليكونوا جزءًا من دفعة الربيع! قوموا بإلقاء نظرة على ابتكاراتهم:
@kinteractapp@admetsys#صندوق_محمد_بن_راشد_للابتكار#دفعة_الربيع#مسرع_صندوق_محمد_بن_راشد_للابتكار#ابتكلر#الإمارات#دبي#أبوظبيHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Study data from
@Admetsys' 2nd clinical trial series (aka stress trial) has been published in the Journal of Diabetes Science and Technology, a peer-reviewed scientific journal by@DiabetesTechSoc. See the abstract authored by@NielsEjskjaer@KimHoulind at https://journals.sagepub.com/doi/full/10.1177/1932296819832876 …pic.twitter.com/4fJcp2gpLO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to our friend, advocate and investor,
@T1DExchange, for the positive coverage of@Admetsys'#ArtificialPancreas for#Hospital#Glucose Control as part of their article, "A Critical Need for a Hospital-based Solution." Read more here at https://www.linkedin.com/pulse/critical-need-hospital-based-solution-shahd-husein-mph/ …pic.twitter.com/NAWG1Hoo1b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Neither snow nor sleet would keep the
@Admetsys team from joining@ianmashiter, Rebecca Love at@ryaltoapp, Marion McNabb @ C3RN &@Bullard_MD at@BU_Tweets@InnovateBU IDEA 2019 Conference#IDEACon19 to talk about, "Where Do Ideas Come From?" Great presentations and panel talk!pic.twitter.com/kqjON4UHWo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
We want to give special recognition to
@TMCInnovation for supporting@IntuiTapMedical,@noninvasix,@admetsys who did great in past years' competitions. We look forward to seeing the great companies they send over this year! Apply before March 3rd at http://texasnvc.orgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Come see
@Admetsys' COO present on March 2nd at@BU_Tweets@InnovateBU IDEA 2019 Conference#IDEACon19 during the morning session, "Where Do Ideas Come From?" Learn more and register here at http://www.bu.edu/innovate/build-your-idea/signature-programs/idea-conference/ …pic.twitter.com/aJ1XYSvukd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
Continued efforts working closely with http://www.Admetsys.com to avoid hypo’s, infections, longer stay’s and increased costs for
#hospitalized#people with#diabetes -@AalborgUH@AAUsund#Steno_Nord@Admetsys@DiabetesDK @AmDiabetesAssn Article: http://ncbi.nlm.nih.gov/pubmed/30678470 pic.twitter.com/wVI1vsxS7y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Admetsys proslijedio/la je Tweet
Glucose variability is associated with complications like reduce quality of live
#ATTD2019pic.twitter.com/Q8qynonRZC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to
@ATTDconf and their awesome team for extending a Startup Grant to@Admetsys so we could attend and present at#ATTD2019 in#Berlin this week.pic.twitter.com/Y2m1qw06uI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great presentation by Anne Cunningham, RN, MBA (
@Admetsys' Director of Strategy) on “Improving the Standard of Care through Inpatient Automated Glycemic Control” at@ATTDconf#ATTD2019 in#Berlin yesterday.#ArtificialPancreaspic.twitter.com/Xyx2cfdCKp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.